A phase I/II study to evaluate the effect of fractionated hemibody irradiation in the treatment of osseous metastases - RTOG 88-22

International Journal of Radiation Oncology Biology Physics

Volumn 36, Issue 1, 1996, Pages 37-48

  Scarantino, C W ^a   Caplan, R ^b   Rotman, M ^c   Coughlin, C ^d   Demas, W ^e   Delrowe, J ^f  

^a Rex Cancer Center   (United States)

^b AMERICAN COLLEGE OF RADIOLOGY   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^e AKRON CITY HOSPITAL   (United States)

^f MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Fractionation; Hemibody irradiation; Occult metastases

Indexed keywords

ADULT; ARTICLE; BLOOD TOXICITY; BONE METASTASIS; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MAXIMUM ALLOWABLE CONCENTRATION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE;

EID: 0029813797     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00247-7     Document Type: Article

References (30)

1. H.L. Abrams R. Spiro N. Goldstein Metastases in carcinoma. Analysis of 1000 autopsied cases Cancer 23 1950 74 85
2. W.M. Court-Brown Symptomatic disturbance after single therapeutic dose of x-rays Br. Med. J. 1 1953 802 804
3. D.R. Cox Regression models and life tables J. R. Stat. Soc. [B] 34 1972 187 229
4. J.D. Cox J. Stetz T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and European Organization for Research and Treatment of Cancer (EORTC) Int. J. Radiat. Oncol. Biol. Phys. 31 1995 1341 1346
5. P.J. Fitzpatrick W. Rider Half body radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 1 1976 197 207
6. C. Freyer P. Fitzpatrick W. Rider P. Poon Radiation pneumonitis: Experience following a large single dose of radiation Int. J. Radiat. Oncol. Biol. Phys. 4 1978 931 936
7. J.E. Groopman J.M. Molina D.T. Scadden Hematopoietic growth factors: Biology and clinical applications N. Engl. J. Med. 321 1989 1449 1459
8. T.A. Hazra S. Gini Prophylactic pelvic girdle irradiation in the treatment of prostatic carcinoma Int. J. Radiat. Oncol. Biol. Phys. 7 1981 817 819
9. F.R. Hendrickson W.M. Shehata A.B. Kirchner Radiation therapy for osseous metastasis Int. J. Radiat. Oncol. Biol. Phys. 1 1976 275 278
10. A. Hercbergs A. Werner H. Brenner Reduced thoracic vertebrae metastases following post mastectomy parasternal irradiation Int. J. Radiat. Oncol. Biol. Phys. 11 1984 773 776
11. J.D. Kalbfleish R.L. Prentice The statistical analysis of failure time data 1980 John Wiley and Sons New York
12. E.L. Kaplan P. Meier Nonparamatric estimation from incomplete observations J. Am. Stat. Assoc. 53 1958 457 481
13. I.D. Kaplan R. Valdagni R.S. Cox M.A. Bagshaw Reduction of spinal metastases after preemptive irradiation in prostatic cancer Int. J. Radiat. Oncol. Biol. Phys. 18 1990 1019 1025
14. C.W. Keen Half body radiotherapy in the management of metastatic carcinoma of the prostate J. Urol. 123 1980 713 715
15. G.J. Lieschke A.W. Burgess Granulocyte colony-stimulating factor and granuloctye macrophage colony stimulating factor N. Engl. J. Med. 327 1992 28 35
16. G.J. Lieshke A.W. Burgess Granulocyte colony-stimulating factor and granulocyte macrophage colony stimulating factor N. Engl. J. Med. 327 1992 99 106
17. M.B. Maclenna S.M. Hosni P. Rubin Sequential hemibody radiotherapy in poor prognosis localized adenocarcinoma of the prostate gland, a preliminary study of the RTOG Int. J. Radiat. Oncol. Biol Phys. 16 1989 001 004
18. C. Poulter D. Cosmatos P. Rubin R. Urtasun J.S. Cooper R.R. Kuske N. Hornback C. Coughlin I. Weigensberg M. Rotman A report of RTOG 82-06: A phase III study of whether the addition of single dose hemibody irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases Int. Radiat. Oncol. Biol. Phys. 23 1992 207 214
19. F. Prato R. Kurdyak e. Saibil J. Carruthers W. Rider N. Aspin The incidence of radiation pneumonitis as a result of single fraction upper half body irradiation Cancer 39 1976 71 78
20. M.M. Quasim Half body irradiation (HBI) in metastatic carcinomas Clin. Radiol. 32 1981 215 219
21. G.J.C. Rees Influence of parasternal radiotherapy for breast carcinoma on thoracic vertebral metastases Radiother. Oncol. 10 1987 183 186
22. C.G. Rowland P.J. Bullimore P.J. Smith Half-body irradiation in the treatment of metastatic prostatic carcinoma Br. J. Urol. 53 1981 628 631
23. P. Rubin L.S. Constine C. Scarantino The paradoxes in patterns and mechanisms of bone marrow regeneration after irradiation II. Total body irradiation Radiother. Oncol. 2 1984 227 233
24. O.M. Salazar P. Rubin F. Hendrickson R. Kamaki C. Poulter J. Newall S. Asbell M. Mouhuddin J. Van Ess Single dose half-body irradiation for palliation of multiple bone metastases from solid tumors: Final Radiation Therapy Oncology Group Report Cancer 58 1986 29 36
25. O. Salazar P. Rubin B. Keller C. Scarantino Systemic (half-body) radiation therapy: Response and toxicity Int. J. Radiat. Oncol. Biol. 4 1978 937 950
26. O.M. Salazar C.W. Scarantino P. Rubin M.L. Feldstein B.E. Keller Total (half-body) systemic irradiation for occult metastases in non-small lung cancer. A Eastern Cooperative Oncology Group Pilot Report Cancer 46 1980 1932 1944
27. C. Scarantino R.D. Ornitz L.G. Hoffman R.F. Anderson On the mechanism of radiation induced emesis: The role of serotonin Int. J. Radiat. Oncol. Biol. Phys. 30 1994 825 830
28. C. Scarantino P. Rubin L. Constine The paradoxes in patterns and mechanisms of bone marrow regeneration after irradiation. I. Different volumes and doses Radiother. Oncol. 2 1984 215 225
29. E. Silverberg J. Lubera Cancer Statistics 1987 CA 37 1987 2 20
30. M.J. Zelefsky H.I. Scher J.D. Forman L.A. Jinares T. Curley Z. Fuks Palliative hemiskeletal irradiation for widespread metastatic prostate cancer. A comparison of single dose and fractionated regimens Int. J. Radiat. Oncol. Biol. Phys. 17 1989 1281 1285